Ethics declarations Ethics approval and consent to participate This study received approval from the Institutional Review Board (IRB) of the Federal University of Minas Gerais (UFMG) (CAAE3768820.1.0000.5149)
Conen, D, Ke Wang, M, Popova, E, Chan, MT, Landoni, G, Cata, JP, Reimer, C, McLean, SR, Srinathan, S, Reyes, JT, Grande, AM, Tallada, AG, Sessler, DI, Fleischmann, E, Kabon, B, Voltolini, L, Cruz, P, Maziak, D, Gutirrez-Soriano, L, McIntyre, WF, Tandon, V, Martnez-Tllez, E, Guerra-Londono, JJ, DuMerton, D, Wong, RH, McGuire, AL, Kidane, B, Roux, DP, Shargall, Y, Wells, JR, Ofori, SN, Vincent, J, Xu, L, Li, Z, Eikelboom, JW, Jolly, SS, Healey, JS, Devereaux, PJ, Wang, MK, Wells, JR, Healey, JS, McIntyre, WF, Sessler, DI, Rajaram, R, Vaporciyan, AA, Mehran, RJ, Sepesi, B, Walsh, GL, Rice, DC , Swisher, SG
However, more studies are needed to confirm these effects
V theo mnh, hiu qu nhanh hay chm, cn ty thuc vo tng loi sn phm, c a, cng nh cch bo v chm sc da ca mi bn
Thus, GSTO1 is an attractive pharmacological target, for which, there is a need for potent and selective inhibitors
